He studied Psychology at the Otto-von-Guericke University in Magdeburg, Germany, and within his Diploma thesis investigated the antidepressant-like properties of LSD in an animal model of depression. Currently, Tobias Buchborn concludes his PhD thesis in Neuroscience at the Institute of Pharmacology and Toxicology in Magdeburg. His research addresses the behavioural and molecular biological correlates of tolerance to LSD, DMT, and DOB. In June 2016, Tobias Buchborn will start working as a Marie Curie Fellow at the Imperial College in London. Here, his research will be devoted to the relevance of 5-HT2A-glutamate interaction and cortical layer V pyramidal cells for the action of serotonergic hallucinogens.